Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $41.8000 (-1.88%) ($40.2900 - $47.9000) on Wed. Jul. 6, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.11% (three month average) | RSI | 53 | Latest Price | $41.8000(-1.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.7% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(8%) SKYY(8%) ARKK(7%) EWI(7%) IVE(7%) | Factors Impacting CAPR price | CAPR will decline at least -3.055% in a week (0% probabilities). TLT(-6%) VIXM(-5%) GLD(-4%) GDX(-4%) VCSH(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.055% (StdDev 6.11%) | Hourly BBV | 0 () | Intraday Trend | -11.3% | | | |
|
5 Day Moving Average | $40.99(1.98%) | 10 Day Moving Average | $41.48(0.77%) | 20 Day Moving Average | $40.49(3.24%) | To recent high | -12% | To recent low | 51.3% | Market Cap | $823m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |